KKR has acquired a majority stake in HealthCare Royalty Partners, pushing the investment firm further into the healthcare ...

KKR & Co. Inc., a leading global investment firm, today announced that it has acquired a majority ownership stake in ...

Investment firm KKR (NYSE:KKR) announced on Wednesday the acquisition of a majority stake in biopharma royalty acquisition company, HealthCare Royalty Partners. The acquisition marks KKR's expansion ...

As part of the transaction, HCRx Chairman and CEO Clarke Futch will continue to lead the HCRx team and will maintain an ongoing substantial minority interest in HCRx.

KKR executives said strong momentum in their business gave them confidence on Thursday of beating earnings targets for 2026, ...

KKR plows deeper into industry with HealthCare Royalty Partners investment; Why Vinay Prasad resigned from the FDA after less than three months; Indie scientific groups step into the gap for ...

Detailed price information for KKR & Company LP (KKR-N) from The Globe and Mail including charting and trades.

Private equity firms KKR and Stonepeak Partners raised their offer for Britain's Assura on Wednesday to almost 1.7 billion pounds ($2.3 billion), topping a rival bid with their "best and final ...